Holen Sie sich die Stockscreener-App
1.22
0.81%
-0.01
Handel nachbörslich:
1.22
Schlusskurs vom Vortag:
$1.23
Offen:
$1.23
24-Stunden-Volumen:
1.01M
Relative Volume:
0.85
Marktkapitalisierung:
$159.94M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1296
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
+0.83%
1M Leistung:
+11.93%
6M Leistung:
+9.91%
1J Leistung:
+37.46%
1-Tages-Spanne:
$1.19
$1.27
1-Wochen-Bereich:
$1.05
$1.6293
52-Wochen-Spanne:
$0.8713
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.22 | 161.25M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Lucid Diagnostics Wins U.S. Department of Veterans Affairs Contract for EsoGuard - marketscreener.com
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com UK
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Lucid Diagnostics rises after winning VA contract for cancer test - TradingView
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Barchart.com
Aug Gainers: Is Lucid Diagnostics Inc stock a top performer YTD2025 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Forecast Cut: Is Lucid Diagnostics Inc gaining market share2025 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Why Lucid Diagnostics Inc. stock remains on buy listsWeekly Risk Report & Consistent Profit Trade Alerts - ulpravda.ru
Lucid Diagnostics Insider Ups Holding By 162% During Year - Yahoo Finance UK
How analysts rate Lucid Diagnostics Inc. stock todayShare Buyback & Consistent Profit Alerts - ulpravda.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9% – Here’s Why - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9%Here's Why - MarketBeat
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed Announces Reverse Stock Split - marketscreener.com
PAVmed Announces Reverse Stock Split - Benzinga
Ideas Watch: Will Lucid Diagnostics Inc stock see PE expansionWeekly Investment Summary & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Bull Run: Why Lucid Diagnostics Inc stock remains on buy listsJuly 2025 Gainers & Community Verified Trade Signals - Bộ Nội Vụ
Here’s Why Lucid Diagnostics (LUCD) Declined in Q3 - Insider Monkey
Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN
With Lucid Diagnostics Stock Surging, Have You Considered The Downside? - Trefis
Can Lucid Diagnostics Inc. stock reach $100 price targetJuly 2025 Momentum & Comprehensive Market Scan Reports - Улправда
What valuation multiples suggest for Lucid Diagnostics Inc. stockJuly 2025 WrapUp & Smart Allocation Stock Tips - DonanımHaber
Can Lucid Diagnostics Inc. stock rebound after recent weakness2025 Trade Ideas & Free Safe Capital Growth Stock Tips - DonanımHaber
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):